Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2011 Filed Jan 27, 2011 23:12 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
GrantRestricted Stock Unit · Derivative | 58,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005341 · doc4.xml · derivative · entry 1 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,616 Underlying: Common Stock · 58,616 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:15 UTC |
Deane Frank MPresident, Mfg. Operations
|
GrantRestricted Stock Unit · Derivative | 37,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005343 · doc4.xml · derivative · entry 1 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,368 Underlying: Common Stock · 37,368 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:17 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GrantRestricted Stock Unit · Derivative | 219,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005347 · doc4.xml · derivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,812 Underlying: Common Stock · 219,812 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:19 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
GrantRestricted Stock Unit · Derivative | 16,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005349 · doc4.xml · derivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,474 Underlying: Common Stock · 16,474 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:22 UTC |
Rice Derica WEVP-Global Services and CFO
|
GrantRestricted Stock Unit · Derivative | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005353 · doc4.xml · derivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,924 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 14, 2011 Filed Jan 18, 2011 18:24 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $34.87 | $108,097.00 |
DisclosureSEC source: 0001209191-11-003397 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,930 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| December 16, 2010 Filed Dec 17, 2010 20:54 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $35.10 | $108,810.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,030 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| December 14, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 8,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 6 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,700 Read SEC document |
| December 09, 2010 Filed Dec 17, 2010 20:54 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,130 Read SEC document |
| December 07, 2010 Filed Dec 17, 2010 20:54 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,235 Read SEC document |
| December 06, 2010 Filed Dec 17, 2010 20:54 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,295 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:20 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057415 · doc4.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,396 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:25 UTC |
BISCHOFF WINFRIED F W SIRDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057417 · doc4.xml · nonDerivative · entry 1 BISCHOFF WINFRIED F W SIR · CIK 0001196150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,336 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:30 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057419 · doc4.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,381 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:35 UTC |
FELDSTEIN MARTIN SDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057422 · doc4.xml · nonDerivative · entry 1 FELDSTEIN MARTIN S · CIK 0001236596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,448 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:43 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057427 · doc4.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,731 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 14:58 UTC |
GILMAN ALFRED GDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057431 · doc4.xml · nonDerivative · entry 1 GILMAN ALFRED G · CIK 0001225473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,173 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:03 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057434 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,175 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:06 UTC |
HORN KAREN NDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057436 · doc4.xml · nonDerivative · entry 1 HORN KAREN N · CIK 0001136550 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,915 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:09 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057438 · doc4.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,448 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:12 UTC |
OBERHELMAN DOUGLAS RDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057440 · doc4.xml · nonDerivative · entry 1 OBERHELMAN DOUGLAS R · CIK 0001171770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,396 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:15 UTC |
PRENDERGAST FRANKLYN GDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057442 · doc4.xml · nonDerivative · entry 1 PRENDERGAST FRANKLYN G · CIK 0001233256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,682 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:18 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057444 · doc4.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,639 Read SEC document |
| November 16, 2010 Filed Nov 17, 2010 19:10 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $34.43 | $106,733.00 |
DisclosureSEC source: 0001209191-10-055440 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,340 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| November 09, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 2,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 14 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · John C. Lechleiter 2008 11-2 GRAT Disclosed balance after: 0 F2 · ownership.direct: Grantor retained annuity trust established by reporting person. Reporting person is trustee. Read SEC document |
| October 25, 2010 Filed Jan 31, 2011 15:08 UTC |
Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005651 · doc5.xml · nonDerivative · entry 2 Nobles Anne · CIK 0001462543 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 5,906 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 18, 2010 Filed Oct 19, 2010 18:51 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 2,489 | $37.76 | $93,984.64 |
DisclosureSEC source: 0001209191-10-050887 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,238 Read SEC document |
| October 15, 2010 Filed Oct 19, 2010 17:16 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $37.65 | $116,715.00 |
DisclosureSEC source: 0001209191-10-050849 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,440 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| September 16, 2010 Filed Sep 17, 2010 19:16 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $35.55 | $110,205.00 |
DisclosureSEC source: 0001209191-10-046772 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,540 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| August 16, 2010 Filed Aug 18, 2010 16:32 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
SaleCommon Stock | 3,100 | $35.33 | $109,523.00 |
DisclosureSEC source: 0001209191-10-043118 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,640 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| July 27, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 13 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 55,583 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 27, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 5 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,735 Read SEC document |
| July 26, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 12 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 57,013 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 26, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 4 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,305 Read SEC document |
| July 23, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 11 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 58,443 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 23, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,735 Read SEC document |
| July 01, 2010 Filed Jul 2, 2010 13:59 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 787 | $33.50 | $26,364.50 |
DisclosureSEC source: 0001209191-10-036749 · doc4.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Read SEC document |
| June 21, 2010 Filed Jan 31, 2011 14:55 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,930 Read SEC document |
| June 09, 2010 Filed Jan 31, 2011 15:08 UTC |
Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005651 · doc5.xml · nonDerivative · entry 1 Nobles Anne · CIK 0001462543 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 6,990 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| May 03, 2010 Filed Jan 31, 2011 14:55 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,090 Read SEC document |
| May 03, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 10 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 57,013 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 30, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 7,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 9 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 57,022 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 28, 2010 Filed Jan 31, 2011 14:55 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,235 Read SEC document |
| March 31, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 33,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 8 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 64,565 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 31, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 33,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 31,449 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 31, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 33,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,327 Read SEC document |
| March 31, 2010 Filed Jan 31, 2011 15:04 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 33,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005648 · doc5.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,443 Read SEC document |
| March 22, 2010 Filed Jan 31, 2011 14:55 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,410 Read SEC document |
| March 22, 2010 Filed Jan 31, 2011 15:12 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005653 · doc5.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 72,983 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| March 22, 2010 Filed Jan 31, 2011 15:12 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005653 · doc5.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.